EMA issues practical guidance on implementation of pharmacovigilance legislation
This article was originally published in SRA
Executive Summary
The European Medicines Agency has identified some "practical considerations" that drug companies will have to take into account before and after the EU pharmacovigilance legislation comes into force in July1.